Drug Type Fusion protein |
Synonyms Milodistim, Milodistim (USAN/INN), Plasmid Immunex yeast 321 + [4] |
Target |
Action agonists |
Mechanism CD123 agonists(Interleukin-3 receptor subunit alpha agonists), CSF-3R agonists(Colony stimulating factor 3 receptor agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 3 |
First Approval Date- |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D05036 | - | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Chemotherapy-induced damage | Phase 3 | United States | - | |
Chemotherapy-induced damage | Phase 3 | Canada | - | - |
Neutropenia | Phase 3 | United States | - | |
Neutropenia | Phase 3 | Canada | - | - |
Neutropenia | Phase 3 | - | - | |
Thrombocytopenia | Phase 3 | United States | - | |
Thrombocytopenia | Phase 3 | Canada | - | - |
Thrombocytopenia | Phase 3 | - | - |